Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 32, Issue 1, Pages 375-402
Publisher
Informa UK Limited
Online
2017-03-09
DOI
10.1080/14756366.2016.1256881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process
- (2015) Michel Perron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chemotherapy of respiratory syncytial virus infections: the final breakthrough
- (2015) Erik De Clercq INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular mechanism of respiratory syncytial virus fusion inhibitors
- (2015) Michael B Battles et al. Nature Chemical Biology
- Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model
- (2015) Gabriela Ispas et al. PLoS One
- Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents
- (2014) Michele Tonelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry
- (2014) Rangappa S. Keri et al. Chemical Biology & Drug Design
- Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
- (2014) John P. DeVincenzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
- (2013) Zhiwu Sun et al. Viruses-Basel
- Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2011) Elena Cichero et al. JOURNAL OF MOLECULAR MODELING
- MTD-comsia modelling of HMG-CoA reductase inhibitors
- (2011) Daniel Duda-Seiman et al. JOURNAL OF THE SERBIAN CHEMICAL SOCIETY
- Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives
- (2010) Michele Tonelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists
- (2010) Elena Cichero et al. JOURNAL OF MOLECULAR MODELING
- 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses
- (2010) Elena Cichero et al. JOURNAL OF MOLECULAR MODELING
- Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses
- (2009) Elena Cichero et al. JOURNAL OF MOLECULAR MODELING
- Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
- (2009) PEDIATRICS
- Antiviral Activity of Benzimidazole Derivatives. I. Antiviral Activity of 1-Substituted-2-[(Benzotriazol-1/2-yl)methyl]benzimidazoles
- (2008) Michele Tonelli et al. CHEMISTRY & BIODIVERSITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More